Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

serum prolactin level

Outcome Time Frame:

2weeks and one month after treatment

Safety Issue:

No

Authority:

Iran: Ethics Committee

Study ID:

Turmeric-01

NCT ID:

NCT01344291

Start Date:

July 2011

Completion Date:

August 2012

Related Keywords:

• Hyperprolactinoma
• hyperprolactinoma
• turmeric
• amenorrhea